FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3004131207> ?p ?o ?g. }

• W3004131207 abstract "Effects of triamcinolone acetonide (TA) combined with aminoguanidine (AG) on vascular endothelial function, vascular endothelial growth factor (VEGF) expression and retinal function in diabetic retinopathy (DR) patients were studied. A total of 100 patients with DR admitted to the Taizhou Second People's Hospital Affiliated to Yangzhou University from January 2016 to December 2018 were collected and randomly divided into observation group (n=50) and control group (n=50). The control group was only treated with TA (4 mg), while the observation group was additionally treated with AG (50 mg/kg). The therapeutic effect and adverse reactions were observed, and the changes in blood glucose (GLU), blood lipid, serum inflammatory cytokines and oxidative stress indexes before and after treatment were detected. Moreover, the serum VEGF level was examined, the central macular thickness (CMT), retinal neovascularization (RNV) leakage area and best corrected visual acuity (BCVA) of retinopathy were observed, and the vascular endothelial function indexes such as nitric oxide (NO), endothelin-1 (ET-1) and intercellular adhesion molecule-1 (ICAM-1) were detected. The therapeutic effect in the observation group was significantly better than that in control group (P<0.05). In observation group after treatment, the levels of GLU, total cholesterol (TC), triglyceride (TG), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), myeloperoxidase (MPO), malondialdehyde (MDA) and catalase (CAT) in the serum, VEGF, CMT and RNV, as well as NO, ET-1 and ICAM-1 were remarkably decreased (P<0.05), while those of superoxide dismutase (SOD) and BCVA were evidently increased (P<0.05). The changes were more significant at 3 months after treatment than those at 1 month. TA combined with AG can inhibit inflammation and oxidative stress, improve vascular endothelial function and retinal function and reduce VEGF expression in DR patients. The overall effect of the combined therapy is good, and its application is worth popularizing." @default.
• W3004131207 created "2020-02-07" @default.
• W3004131207 creator A5026498880 @default.
• W3004131207 creator A5078277625 @default.
• W3004131207 creator A5084201020 @default.
• W3004131207 date "2020-01-30" @default.
• W3004131207 modified "2023-10-15" @default.
• W3004131207 title "Triamcinolone acetonide combined with aminoguanidine inhibits inflammation and oxidative stress, improves vascular endothelial and retinal function and reduces VEGF expression in diabetic retinopathy patients" @default.
• W3004131207 cites W147553750 @default.
• W3004131207 cites W1972657864 @default.
• W3004131207 cites W1981168254 @default.
• W3004131207 cites W1984287558 @default.
• W3004131207 cites W1994653065 @default.
• W3004131207 cites W1995363602 @default.
• W3004131207 cites W1999146990 @default.
• W3004131207 cites W2002407466 @default.
• W3004131207 cites W2010708123 @default.
• W3004131207 cites W2019226618 @default.
• W3004131207 cites W2022935004 @default.
• W3004131207 cites W2083922350 @default.
• W3004131207 cites W2098726636 @default.
• W3004131207 cites W2127322315 @default.
• W3004131207 cites W2132949972 @default.
• W3004131207 cites W2137397722 @default.
• W3004131207 cites W2145083074 @default.
• W3004131207 cites W2161011838 @default.
• W3004131207 cites W2171994468 @default.
• W3004131207 cites W2340822548 @default.
• W3004131207 cites W2367151251 @default.
• W3004131207 cites W2546961712 @default.
• W3004131207 cites W2605803181 @default.
• W3004131207 cites W2975995254 @default.
• W3004131207 cites W3012022967 @default.
• W3004131207 cites W2116680504 @default.
• W3004131207 doi "https://doi.org/10.3892/etm.2020.8478" @default.
• W3004131207 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7086164" @default.
• W3004131207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32256730" @default.
• W3004131207 hasPublicationYear "2020" @default.
• W3004131207 type Work @default.
• W3004131207 sameAs 3004131207 @default.
• W3004131207 citedByCount "2" @default.
• W3004131207 countsByYear W30041312072022 @default.
• W3004131207 crossrefType "journal-article" @default.
• W3004131207 hasAuthorship W3004131207A5026498880 @default.
• W3004131207 hasAuthorship W3004131207A5078277625 @default.
• W3004131207 hasAuthorship W3004131207A5084201020 @default.
• W3004131207 hasBestOaLocation W30041312071 @default.
• W3004131207 hasConcept C126322002 @default.
• W3004131207 hasConcept C134018914 @default.
• W3004131207 hasConcept C134659918 @default.
• W3004131207 hasConcept C1491633281 @default.
• W3004131207 hasConcept C167734588 @default.
• W3004131207 hasConcept C203014093 @default.
• W3004131207 hasConcept C203565725 @default.
• W3004131207 hasConcept C2775838275 @default.
• W3004131207 hasConcept C2776151105 @default.
• W3004131207 hasConcept C2776914184 @default.
• W3004131207 hasConcept C2777025900 @default.
• W3004131207 hasConcept C2778313320 @default.
• W3004131207 hasConcept C2778401633 @default.
• W3004131207 hasConcept C2778903070 @default.
• W3004131207 hasConcept C2779829184 @default.
• W3004131207 hasConcept C55493867 @default.
• W3004131207 hasConcept C555293320 @default.
• W3004131207 hasConcept C71924100 @default.
• W3004131207 hasConcept C85789140 @default.
• W3004131207 hasConcept C86803240 @default.
• W3004131207 hasConceptScore W3004131207C126322002 @default.
• W3004131207 hasConceptScore W3004131207C134018914 @default.
• W3004131207 hasConceptScore W3004131207C134659918 @default.
• W3004131207 hasConceptScore W3004131207C1491633281 @default.
• W3004131207 hasConceptScore W3004131207C167734588 @default.
• W3004131207 hasConceptScore W3004131207C203014093 @default.
• W3004131207 hasConceptScore W3004131207C203565725 @default.
• W3004131207 hasConceptScore W3004131207C2775838275 @default.
• W3004131207 hasConceptScore W3004131207C2776151105 @default.
• W3004131207 hasConceptScore W3004131207C2776914184 @default.
• W3004131207 hasConceptScore W3004131207C2777025900 @default.
• W3004131207 hasConceptScore W3004131207C2778313320 @default.
• W3004131207 hasConceptScore W3004131207C2778401633 @default.
• W3004131207 hasConceptScore W3004131207C2778903070 @default.
• W3004131207 hasConceptScore W3004131207C2779829184 @default.
• W3004131207 hasConceptScore W3004131207C55493867 @default.
• W3004131207 hasConceptScore W3004131207C555293320 @default.
• W3004131207 hasConceptScore W3004131207C71924100 @default.
• W3004131207 hasConceptScore W3004131207C85789140 @default.
• W3004131207 hasConceptScore W3004131207C86803240 @default.
• W3004131207 hasLocation W30041312071 @default.
• W3004131207 hasLocation W30041312072 @default.
• W3004131207 hasLocation W30041312073 @default.
• W3004131207 hasLocation W30041312074 @default.
• W3004131207 hasOpenAccess W3004131207 @default.
• W3004131207 hasPrimaryLocation W30041312071 @default.
• W3004131207 hasRelatedWork W195273352 @default.
• W3004131207 hasRelatedWork W1989844152 @default.
• W3004131207 hasRelatedWork W2105141190 @default.
• W3004131207 hasRelatedWork W2171597431 @default.
• W3004131207 hasRelatedWork W2354761138 @default.
• W3004131207 hasRelatedWork W2359632916 @default.
• W3004131207 hasRelatedWork W2367206690 @default.

• next